4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001140361-10-045865
CIK 0001389545other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:10 PM ET
Size
6.2 KB
Accession
0001140361-10-045865
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2008-09-05+35,400→ 272,900 totalExercise: $1.95From: 2009-09-05Exp: 2018-09-05→ Common Stock (35,400 underlying)
Footnotes (2)
- [F1]Original Form 4 filed on September 9, 2008. This amendment is filed to correct the expiration date of the options from September 5, 2019 to September 5, 2018.
- [F2]Original Form 4 filed on September 9, 2008. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 272,900 not 72,900.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:10 PM ET
- Size
- 6.2 KB